{
    "title": "To amend title XVIII of the Social Security Act to provide for the consolidated coverage of home infusion therapy under part B of the Medicare Program.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Medicare Home Infusion Therapy \nConsolidated Coverage Act of 2006''.\n\nSEC. 2. CONSOLIDATION OF MEDICARE COVERAGE OF HOME INFUSION THERAPY \n              UNDER PART B.\n\n    (a) In General.--Section 1861 of the Social Security Act (42 U.S.C. \n1395x) is amended--\n            (1) in subsection (s)(2)--\n                    (A) by striking ``and'' at the end of subparagraph \n                (Z);\n                    (B) by adding ``and'' at the end of subparagraph \n                (AA); and\n                    (C) by adding at the end the following new \n                subparagraph:\n            ``(BB) home infusion therapy (as defined in subsection \n        (ccc)(1));''; and\n            (2) by adding at the end the following new subsection: ``\n\n                        ``Home Infusion Therapy\n\n    ``(ccc)(1) The term `home infusion therapy' means the following \nitems and services furnished to an individual, who is under the care of \na physician, which are provided, except as provided in subparagraph \n(B), by a qualified home infusion therapy provider under a plan (for \nfurnishing such items and services to such individual) established and \nperiodically reviewed by a physician, which items and services are \nprovided in an integrated manner in the individual's home in \nconformance with clinical standards of care established by the \nSecretary (after taking into account the standards commonly used for \nhome infusion therapy by Medicare Advantage organizations and \naccreditation organizations)--\n                    ``(A) infusion drugs (as defined in paragraph \n                (2)(B));\n                    ``(B) nursing services provided, directly or by an \n                accredited homecare organization under arrangements \n                made, by the qualified home infusion therapy provider, \n                in connection with such infusion; and\n                    ``(C) other professional services (including \n                pharmacy and care coordination services) and related \n                items and services (including medical supplies, \n                intravenous fluids, home delivery, equipment, and other \n                items and services the Secretary determines \n                appropriate) to administer infusion drug therapies to \n                an individual safely and effectively in the home;\n        except that such term does not include nursing services to the \n        extent they are covered as home health services.\n            ``(2) For purposes of paragraph (1):\n                    ``(A) The term `home' means a place of residence \n                used as an individual's home and includes such \n                alternate settings as the Secretary determines.\n                    ``(B) The term `infusion drugs' means parenteral \n                drugs and biologicals administered via an intravenous, \n                intraspinal, intra-arterial, intrathecal, subcutaneous, \n                or intramuscular access device inserted into the body.\n                    ``(C) The term `qualified home infusion therapy \n                provider' means any pharmacy that--\n                            ``(i) has expertise in the preparation of \n                        compounded sterile preparations in compliance \n                        with enforceable standards of the U.S. \n                        Pharmacopoeia or other nationally recognized \n                        standards that regulate compounding of sterile \n                        preparations as determined by the Secretary;\n                            ``(ii) provides infusion therapy to \n                        patients with acute or chronic conditions \n                        requiring parenteral administration of drugs \n                        and biologicals administered through catheters \n                        or needles, or both, in a home; and\n                            ``(iii) meets such requirements as the \n                        Secretary determines are necessary to ensure \n                        the safe and effective provision of home \n                        infusion therapy (taking into account the \n                        standards of care for home infusion therapy \n                        established by private payers).''.\n    (b) Payment for Home Infusion Therapy.--\n            (1) In general.--Section 1834 of such Act (42 U.S.C. 1395m) \n        is amended by adding at the end the following new subsection:\n    ``(n) Payment for Home Infusion Therapy.--The payment amount under \nthis part for home infusion therapy is determined as follows:\n            ``(1) In general.--Except as provided in this subsection, \n        the Secretary shall determine a per diem schedule for payment \n        for home infusion therapy (including pharmacy services, \n        administration services, care coordination services, supplies \n        and equipment necessary to safely and properly administer a \n        home infusion drug or biological in accordance with the \n        requirements and clinical standards commonly used for home \n        infusion therapy) which reflects the reasonable costs which \n        must be incurred by efficiently and economically operated \n        qualified home infusion therapy providers to provide such \n        therapy in conformity with applicable State and Federal laws, \n        regulations, and quality and safety standards and to assure \n        that Medicare beneficiaries have reasonable access to such \n        therapy.\n            ``(2) Infusion drugs.--\n                    ``(A) In general.--Except as provided in \n                subparagraph (B), the provisions of section 1847A shall \n                apply to payment under this part for drugs included in \n                home infusion therapy.\n                    ``(B) Special rule.--In applying subparagraph (A), \n                the determination of average sales prices under section \n                1847A shall be limited to such prices for infusion drug \n                sales to home infusion therapy pharmacies.''.\n            (2) Conforming amendments.--\n                    (A) Section 1833(a)(1) of such Act (42 U.S.C. \n                1395l(a)(1)) is amended by striking ``and'' before \n                ``(V)'' and by inserting before the semicolon at the \n                end the following: ``, and (W) with respect to home \n                infusion therapy, the amounts paid shall be determined \n                under section 1834(n)''.\n                    (B) The first sentence of section 1842(b)(6) of \n                such Act (42 U.S.C. 1395u(b)(6)) is amended by striking \n                ``and'' before ``(H)'' and by inserting before the \n                period at the end the following: ``, and (I) in the \n                case of home infusion therapy, payment shall be made to \n                the qualified home infusion therapy provider \n                responsible for furnishing the therapy''.\n    (c) Other Conforming Provisions.--\n            (1) Exclusion from durable medical equipment benefit.--\n        Section 1861(n) of such Act (42 U.S.C. 1395x(n)) is amended by \n        adding at the end the following: ``Such term does not include \n        home infusion therapy.''.\n            (2) Application of accreditation organization provisions.--\n        The provisions of section 1865(b) of the Social Security Act \n        apply to accreditation of qualified home infusion therapy \n        providers.\n    (d) Effective Date.--The amendments made by this section shall \napply to home infusion therapy furnished on or after January 1, 2007."
}